Related references
Note: Only part of the references are listed.Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
Simon Gengler et al.
NEUROBIOLOGY OF AGING (2012)
Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance
D. W. Porter et al.
DIABETES OBESITY & METABOLISM (2010)
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
Paula L. McClean et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet
V. A. Gault et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer's disease?
Christian Hoelscher et al.
NEUROBIOLOGY OF AGING (2010)
A high-fat diet impairs neurogenesis: Involvement of lipid peroxidation and brain-derived neurotrophic factor
Hee Ra Park et al.
NEUROSCIENCE LETTERS (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Impaired neurogenesis in adult type-2 diabetic rats
Bradley T. Lang et al.
BRAIN RESEARCH (2009)
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
David Russell-Jones
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Mathew Blurton-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid
Victor A. Gault et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Changes in neurogenesis in dementia and Alzheimer mouse models: are they functionally relevant?
H. Georg Kuhn et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice
Desu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Maire E. Doyle et al.
PHARMACOLOGY & THERAPEUTICS (2007)
The leptin-deficient (ob/ob) mouse -: A new animal model of peripheral neuropathy of type 2 diabetes and obesity
Viktor R. Drel et al.
DIABETES (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Physical exercise prevents age-related decline in precursor cell activity in the mouse dentate gyrus
Golo Kronenberg et al.
NEUROBIOLOGY OF AGING (2006)
Long-term potentiation enhances neurogenesis in the adult dentate gyrus
Elodie Bruel-Jungerman et al.
JOURNAL OF NEUROSCIENCE (2006)
Fluoxetine targets early progenitor cells in the adult brain
Juan M. Encinas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Natural variation and genetic covariance in adult hippocampal neurogenesis
G Kempermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nerve growth factor, neural stem cells and Alzheimer's disease
Klaus Heese et al.
NEUROSIGNALS (2006)
Glucagon-related peptide 1 (GLP-1): Hormone and neurotransmitter
PJ Larsen et al.
REGULATORY PEPTIDES (2005)
Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation
J Nyberg et al.
JOURNAL OF NEUROSCIENCE (2005)
Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid
BD Green et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Neurodegenerative disorders associated with diabetes mellitus
M Ristow
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Inflammatory blockade restores adult hippocampal neurogenesis
ML Monje et al.
SCIENCE (2003)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
The glucagon-like peptides: a double-edged therapeutic sword?
T Perry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice:: evidence that GIP is the major physiological incretin
VA Gault et al.
DIABETOLOGIA (2003)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Endogenous GLP-1 is involved in β-amyloid protein-induced memory impairment and hippocampal neuronal death in rats
JI Oka et al.
BRAIN RESEARCH (2000)